US supports lifting patent protections on COVID-19 vaccines
“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures. The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines,” United States Trade Representative Katherine Tai said in a statement.
Waiving those protections would theoretically let countries and organizations manufacture patented vaccines without facing repercussions. But they would need to have the expertise and materials on hand to…